Ai Virtual Agent Selection, Implementation and Support Keys to Success
Improving Population Health via Non-traditional Partnerships
Efficient Data Management in the Healthcare Space
Transform Healthcare with a Passion for Innovation
Significant technological change often means a cultural shift for...
NovletMattis, Chief Information Officer, Orlando Health
Disrupting the CIO Comfort Zone to Innovate and Transform How...
Wes Williams, VP & CIO, Mental Health Center Of Denver
Bringing the Worlds of Technology and Health Closer to Each Other
Kristin Myers, Chief Information Officer, Mount Sinai Health System
The Biopsychosocial Model: The Future of Remote Patient Monitoring
Heather Comerci Reyes, Md, Me; Michael Hasselberg, Phd, Chief Digital Health Officer, University Of Rochester Medical Center
Thank you for Subscribing to CIO Applications Weekly Brief

Notable Labs Announces Partnership with myTomorrows

“As an established player in the preapproval access space, we are excited to broaden our reach by partnering with Notable,” said Michel van Harten, chief operating officer of myTomorrows. “We look forward to supporting more patients with critical information on treatment options and providing a pathway to access those treatments.”
FREMONT, CA: Notable, a functional precision medicine company, and myTomorrows, an integrated platform that links patients with an unmet medical need to treatments in development worldwide, announced a strategic partnership.
“We are thrilled to partner with myTomorrows in support of our shared mission of helping patients,” stated Hiroomi Tada, M.D., Ph.D., chief medical officer of Notable. “Our goal is to provide meaningful information and treatment options to myTomorrows to share with patients in their network for whom standard treatments have been exhausted.”
Clinical researchers and physicians collaborating with Notable can be referred to myTomorrows to investigate preapproval treatment options for their patients. Patients can also be directly referred to myTomorrows’ platform to find and look for access to preapproval treatment options. In parallel, myTomorrows will streamline appropriate physician and patient referrals to Notable to utilize their testing platform to find out potential clinical studies that are being conducted in collaboration with researchers in Notable’s network. myTomorrows may further help physicians at these partner institutions in finding options for their other patients.
“As an established player in the preapproval access space, we are excited to broaden our reach by partnering with Notable,” said Michel van Harten, chief operating officer of myTomorrows. “We look forward to supporting more patients with critical information on treatment options and providing a pathway to access those treatments.”
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
Featured Vendors
-
Jason Vogel, Senior Director of Product Strategy & Development, Silver Wealth Technologies
James Brown, CEO, Smart Communications
Deepak Dube, Founder and CEO, Datanomers
Tory Hazard, CEO, Institutional Cash Distributors
Jean Jacques Borno, CFP®, Founder & CEO, 1787fp
-
Andrew Rudd, CEO, Advisor Software
Douglas Jones, Vice President Operations, NETSOL Technologies
Matt McCormick, CEO, AddOn Networks
Jeff Peters, President, and Co-Founder, Focalized Networks
Tom Jordan, VP, Financial Software Solutions, Digital Check Corp
Tracey Dunlap, Chief Experience Officer, Zenmonics